Total funding allocated to projects this organisation participated or coordinated
Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.
Total number of projects: 6
As coordinator: 4
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 2*
*Ratio includes only projects with > 2 partners
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2006 | 297.300 | 300.000 | 146.600 | 2 | 2 | |
2004 | 266.250 | 0 | 38.036 | 2 |
Total number of partners:8661
Partner loyalty:
Frequent Partner: (> 2 projects): 5328
Rare Partner: 3333
Frequent / Rare Partner Ratio: 1.6
Category: | No: |
---|---|
BIOLOGICAL SCIENCES | 473 |
RTD HORIZONTAL TOPICS | 353 |
SOCIAL AND ECONOMIC CONCERNS | 226 |
PROTECTING MAN AND HIS ENVIRON | 98 |
INDUSTRY AND TECHNOLOGY | 52 |
AGRICULTURE AND MARINE RESOURC | 35 |
ENERGY | 19 |
MEASUREMENTS AND STANDARDS | 12 |
PHYSICAL AND EXACT SCIENCES | 8 |
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2006-10-01 | Polymorphic variations in apoptotic genes and cancer predisposition | INTAS 2005-1000008- | participant | 150.000 | 5 |
2006-06-01 | Analysis of the alternatively spliced isoforms of human intersectin 1 and 2: characterization of their expression patterns in normal and tumour tissues | INTAS 2005-1000004- | participant | 150.000 | 4 |
2006-06-01 | Viral polymorphisms and clinical course of human Hepatitis C virus infection | INTAS 2005-1000004- | coordinator | 150.000 | 5 |
2006-05-01 | The role of peroxiredoxin V in antioxidant defence, apoptosis and regulation of transcription | INTAS 2005-1000004- | coordinator | 147.300 | 3 |
2004-09-01 | Not I micro-arrays for identification of new cancer-causing genes | INTAS 2003-51-4983 | coordinator | 133.125 | 7 |
2004-09-01 | Not I microarrays for identification of new cancer-causing genes. | coordinator | 133.125 | 7 |